Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The monoaminergic system refers to the network of neurons that utilize monoamine neurotransmitters, including serotonin, dopamine, norepinephrine, epinephrine, and histamine. This system plays crucial roles in regulating emotion, arousal, attention, memory, motor control, and autonomic functions. It is also involved in the modulation of neurotrophic factors. The monoaminergic system is a major target for drugs treating psychiatric and neurological disorders.
Various, including receptor agonism/antagonism, reuptake inhibition, enzyme inhibition, and modulation of neurotransmitter release.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Monoaminergic System.